Commentary – Pharmaceutical Technology: “Cannabinoids receptors: popular preclinical target but banned in 137 countries”

Commentary – Pharmaceutical Technology: “Cannabinoids receptors: popular preclinical target but banned in 137 countries”
CANNANNEW REPORT

Cannabinoid receptors are currently the most popular targets for CNS in preclinical development, with 391 drugs tagged in total. Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. In 2022, a surge in the pipeline has led […]

Excerpt only …
READ MORE BELOW
Source : Commentary – Pharmaceutical Technology: “Cannabinoids receptors: popular preclinical target but banned in 137 countries”

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.